Login / Signup

Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis.

Komal EjazDania AbidPaul JuneauJun ChuSarfaraz Hasni
Published in: Lupus (2022)
Long-term follow-up studies are needed to establish the efficacy and safety of GnRHa use for ovarian preservation.
Keyphrases
  • systemic lupus erythematosus
  • low dose
  • disease activity
  • high dose
  • case control
  • rheumatoid arthritis